Story perspectives

New Center Opens Amid Long COVID Treatment Challenges

10/21/2025

47 10

Summary

Story summary

A recent clinical trial found colchicine did not improve functional capacity or respiratory function in adults with long COVID.
Antivirals such as nirmatrelvir-ritonavir have shown limited effectiveness in improving long COVID symptoms.
Pediatric long COVID affects an estimated 1.3 to 6.5 million children, yet research on this group is lacking.
A new long COVID treatment center in Traverse City aims to provide comprehensive care for affected individuals.

1 of 1

Story summary

A recent clinical trial found colchicine did not improve functional capacity or respiratory function in adults with long COVID.
Antivirals such as nirmatrelvir-ritonavir have shown limited effectiveness in improving long COVID symptoms.
Pediatric long COVID affects an estimated 1.3 to 6.5 million children, yet research on this group is lacking.
A new long COVID treatment center in Traverse City aims to provide comprehensive care for affected individuals.